WO2026094023 - RECOMBINANT ANTIBODY BINDING TO PENICILLIN BINDING PROTEIN 2A (PBP2A)
National phase entry is expected:
Publication Number
WO/2026/094023
Publication Date
07.05.2026
International Application No.
PCT/IB2025/061250
International Filing Date
04.11.2025
Title **
[English]
RECOMBINANT ANTIBODY BINDING TO PENICILLIN BINDING PROTEIN 2A (PBP2A)
[French]
ANTICORPS RECOMBINANT LIANT LA PROTÉINE 2A DE LIAISON À LA PÉNICILLINE (PBP2A)
Applicants **
NANODETECTION TECHNOLOGY, INC.
Inventors
ZHANG, Ying
DURAND, Douglas
Priority Data
24210565.8
04.11.2024
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2193 | |
| EPO | Filing, Examination, Granting | 8921 | |
| Japan | Filing, Examination, Granting | 2122 | |
| South Korea | Filing, Examination, Granting | 2008 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
19,984
Contact Us
Abstract[English]
The present invention relates to recombinant antibodies, isolated from mouse or rabbit phage library, that bind to penicillin binding protein 2A (PBP2a) of methicillin-resistant Staphylococcus aureus (MRSA) used for the detection of PBP2a.[French]
La présente invention concerne des anticorps recombinants, isolés à partir d'une banque de phages de souris ou de lapin, qui se lient à la protéine 2A de liaison à la pénicilline (PBP2a) de Staphylococcus aureus résistant à la méthicilline (MRSA) utilisés pour la détection de PBP2a.